跳至主要内容
临床试验/JPRN-UMIN000018230
JPRN-UMIN000018230招募中未知

Immunological persistence after booster doses of the inactivated polio vaccine - Immunological persistence after booster doses of the inactivated polio vaccine

Tokyo Medical University0 个研究点目标入组 30 人开始时间: 2015年7月7日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • acute febrile illness immunodeficiency allergy against vaccine contents pregnancy

研究者

相似试验

进行中(未招募)
1 期
Study to Evaluate the Immune Response after a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Alone or Concomitantly with a Licensed Meningococcal Serogroup B Vaccine,in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)Healthy volunteers (active immunization against invasive meningogoccal disease (IMD) caused by Meningococcal serogroups A, C, Y and W)MedDRA version: 20.0Level: PTClassification code 10027274Term: Meningococcal infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2019-004461-41-Outside-EU/EEASanofi Pasteur Inc570
已完成
不适用
Immunogenicity and cross-immunity after booster immunization with adjuvanted whole virion A (H5N1) vaccine of Qinghai straiPrevention of influenza
JPRN-UMIN000004169Clinical Research Center, National Hospital Organization320
已完成
不适用
Immunogenicity and cross-immunity after booster immunization with adjuvanted whole virion A (H5N1) vaccine of Qinghai strain Part2 Immunization effect on adults who might be exposed to H5N1 viral componentsPrevention of influenza
JPRN-UMIN000004788Clinical Research Center, National Hospital Organization300
进行中(未招募)
不适用
Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous DoseActive immunization against tetanus, diphtheria and pertussisMedDRA version: 18.1Level: PTClassification code 10054129Term: Diphtheria immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.1Level: PTClassification code 10069577Term: Pertussis immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.1Level: PTClassification code 10054131Term: Tetanus immunisationSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2015-005842-69-Outside-EU/EEASanofi Pasteur Limited789
已完成
4 期
Intradermal second booster COVID-19 vaccinatioThe second booster intradermal mRNA-based vaccine following the 2-dose primary series of ChAdOx1 (AstraZeneca) can provide a sufficient level of immunity against SAR-CoV-2.booster vaccine, SAR-CoV2, older adult, intradermal vaccination, elderly, Thailand
TCTR20230411008Faculty of Medicine Siriraj hospital, Mahidol University107